Who founded Endeavor Biomedicines?

Endeavor Biomedicines was founded by John Hood in 2018.

Who are Endeavor Biomedicines's investors?

Endeavor Biomedicines's investors include Fidelity Investments, Longitude Capital.

How much funding has Endeavor Biomedicines raised?

Endeavor Biomedicines has disclosed $221.7M raised across 2 rounds.

Where is Endeavor Biomedicines headquartered?

Endeavor Biomedicines is headquartered in San Diego, US.

Endeavor Biomedicines

San Diego, US · Founded 2018 · Delaware corporation · 52 employees on LinkedIn · 2 known investors

Endeavor BioMedicines is a biopharmaceutical company developing medicines aimed at treating patients with serious, intractable diseases, with the goal of altering disease progression rather than only slowing it.

Biotech

Founders & leadership

Endeavor Biomedicines was founded in 2018 by John Hood.

John HoodinFounder

Wing Cheong LamNamed on SEC filing

Bernard DavitianNamed on SEC filing

Raghu SaripalliNamed on SEC filing

Monal MehtaNamed on SEC filing

Miguel de los RiosNamed on SEC filing

Board

Patrick G. Enright inBoard MemberManaging Director at Longitude Capital

Investors · 2

Fidelity Investments✓ verifiedBoston

Longitude CapitalMenlo Park · $10M – $30M

Reported raises · per SEC filings

Form D private placements

$221.7M disclosed across 2 rounds · 2022–2024

▶$132.6MraisedMay 2024 · 32 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Patrick G. EnrightDirector
Bernard DavitianDirector
John HoodExecutive Officer, Director
Vishaal TurakhiaExecutive Officer
Chris KruegerExecutive Officer
Enoch KariukiExecutive Officer
Karan TakharDirector
Miguel de los RiosExecutive Officer
Monal MehtaDirector
Wing Cheong LamDirector

Offering amount: $132.6M
Amount sold: $132.6M
First sale: Apr 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$89.1MraisedFeb 2022 · 16 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Wing Cheong LamDirector
Bernard DavitianDirector
Raghu SaripalliExecutive Officer
John HoodDirector, Executive Officer
Monal MehtaDirector
Patrick G. EnrightDirector
Miguel de los RiosExecutive Officer

Offering amount: $101M
Amount sold: $89.1M
First sale: Jan 2022
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

BBG Ventures36 shared keywordsSupercircle operates a recycling infrastructure platform that lets apparel brands take back and recycle used clothing, turning recycling into a revenue channel rather than sending garments to landfill or incineration.

Companies competing with Endeavor Biomedicines for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Endeavor Biomedicines do?: Endeavor BioMedicines is a biopharmaceutical company developing medicines aimed at treating patients with serious, intractable diseases, with the goal of altering disease progression rather than only slowing it.
Who founded Endeavor Biomedicines?: Endeavor Biomedicines was founded by John Hood in 2018.
Who are Endeavor Biomedicines's investors?: Endeavor Biomedicines's investors include Fidelity Investments, Longitude Capital.
How much funding has Endeavor Biomedicines raised?: Endeavor Biomedicines has disclosed $221.7M raised across 2 rounds.
Where is Endeavor Biomedicines headquartered?: Endeavor Biomedicines is headquartered in San Diego, US.